Stocks in the Vines Investor Access Day, held at Marnong Estate, Victoria, where standout presentations included:
BlinkLab Limited (ASX:BB1)
Demonstrating how its app is revolutionising medtech through early autism diagnosis in children.
Decidr AI Industries Ltd (ASX:DAI)
Outlining how Decidr and AWS are powering the next wave of AI‑driven business solutions.
Zelira Therapeutics (ASX:ZLD)
Showcasing advancements in medicinal cannabis treatments for Phelan‑McDermid Syndrome and autism spectrum disorders.
Challenger Gold Limited (ASX:CEL)
Providing an update on its gold exploration strategy, project development progress, and upcoming value‑driving milestones.
Terrain Minerals Ltd (ASX:TMX)
Highlighting its exploration activities, project portfolio, and the catalysts shaping its forward strategy in the resources sector.
Alice Queen Limited (ASX:AQX)
Presenting its exploration progress, geological potential, and the company’s pathway toward value‑creating milestones across its gold and copper assets.
Stocks in the Vines Investor Access Day Highlights
Political Debate Panel
Panelists Kos Samaras, Tony Barry, Danni Hunter, Anthony Koutoufides
How does the 2025 election shape market trends and investor confidence?
In this debate, experts share diverse perspectives on the potential impacts, exploring opportunities, risks, and the broader economic outlook. Hear insightful arguments and contrasting views on what the election could mean for the future of the stock market:
Decidr AI (ASX:DAI) Transforming Business with Innovation
David Brudenell
David Brudenell, Executive Chairman at Decidr AI (ASX:DAI) presentation update. David shares how the company is revolutionizing businesses worldwide through its unique technology. Discover the vision, the impact, and the opportunities Decidr AI is creating in the global market.
Zelira Therapeutics (ASX:ZLD) Advancing Global Cannabinoid Medicines
Tim Slate
In this presentation, CEO Tim Slate provides a clear and compelling update on Zelira Therapeutics’ progress as a global biopharmaceutical company developing clinically validated cannabinoid‑based medicines. He outlines the company’s commercial traction, clinical programs, and the expanding market opportunity across pain, insomnia, and other unmet medical needs. A valuable session for investors seeking exposure to a revenue‑generating biotech with global growth potential.
Blink Lab (ASX:BB1) Transforming MedTech for Autism Diagnosis
Brian Leedman
Brian Leedman Non-Executive Chairman of Blinklab (ASX:BB1) presentation at this year's Stocks in the Vines Investor Access Day covering how Blinklab is revolutionizing the global med‑tech landscape by advancing innovative tools that support the early and accurate diagnosis of Autism in children. Their groundbreaking approach is helping clinicians and families worldwide access better insights and improved outcomes.
Alice Queen (ASX:AQX): Gold & Copper Exploration Update
Andrew Buxton
In this presentation, Executive Chairman Andrew Buxton outlines Alice Queen’s exploration strategy, project portfolio, and forward plans across its key gold and copper assets. He provides insight into recent progress, geological potential, and the company’s pathway toward value‑creating milestones. A concise and informative update for investors seeking exposure to early‑stage resource opportunities with strong discovery upside:
4DS Memory (ASX:4DS) Advancing Next‑Gen ReRAM Technology
David McAuliffe
In this presentation, Executive Director David McAuliffe provides a clear and compelling update on 4DS Memory’s progress in developing next‑generation non‑volatile memory technology. He outlines the company’s technical milestones, strategic partnerships, and the commercial potential of its Interface Switching ReRAM. Investors will gain insight into how 4DS is positioning itself within the global semiconductor landscape and the key catalysts shaping its path forward.
Presenter Perspectives: How Stocks in the Vines Drives Company Growth
“We appreciated getting to present to high quality investors from Melbourne-based funds and stockbrokers to high-net-worth individuals. The combination of fine wine, a beautiful setting, and interesting people made it feel more like a social function than a traditional capital-raising event. If you're a company looking to engage with serious investors in a meaningful way, this is the event to attend.”
Tim Slate, Non-Executive Director
Zelira Therapeutics (ASX:ZLD)
Stocks in the Vines Investor Access Day, held at Marnong Estate, Victoria, where standout presentations included:
BlinkLab Limited (ASX:BB1)
Demonstrating how its app is revolutionising medtech through early autism diagnosis in children.
Decidr AI Industries Ltd (ASX:DAI)
Outlining how Decidr and AWS are powering the next wave of AI‑driven business solutions.
Zelira Therapeutics (ASX:ZLD)
Showcasing advancements in medicinal cannabis treatments for Phelan‑McDermid Syndrome and autism spectrum disorders.
Challenger Gold Limited (ASX:CEL)
Providing an update on its gold exploration strategy, project development progress, and upcoming value‑driving milestones.
Terrain Minerals Ltd (ASX:TMX)
Highlighting its exploration activities, project portfolio, and the catalysts shaping its forward strategy in the resources sector.
Alice Queen Limited (ASX:AQX)
Presenting its exploration progress, geological potential, and the company’s pathway toward value‑creating milestones across its gold and copper assets.
Stocks in the Vines Investor Access Day Highlights
Political Debate Panel
Panelists Kos Samaras, Tony Barry, Danni Hunter, Anthony Koutoufides
How does the 2025 election shape market trends and investor confidence?
In this debate, experts share diverse perspectives on the potential impacts, exploring opportunities, risks, and the broader economic outlook. Hear insightful arguments and contrasting views on what the election could mean for the future of the stock market:
Decidr AI (ASX:DAI) Transforming Business with Innovation
David Brudenell
David Brudenell, Executive Chairman at Decidr AI (ASX:DAI) presentation update. David shares how the company is revolutionizing businesses worldwide through its unique technology. Discover the vision, the impact, and the opportunities Decidr AI is creating in the global market.
Zelira Therapeutics (ASX:ZLD) Advancing Global Cannabinoid Medicines
Tim Slate
In this presentation, CEO Tim Slate provides a clear and compelling update on Zelira Therapeutics’ progress as a global biopharmaceutical company developing clinically validated cannabinoid‑based medicines. He outlines the company’s commercial traction, clinical programs, and the expanding market opportunity across pain, insomnia, and other unmet medical needs. A valuable session for investors seeking exposure to a revenue‑generating biotech with global growth potential.
Blink Lab (ASX:BB1) Transforming MedTech for Autism Diagnosis
Brian Leedman
Brian Leedman Non-Executive Chairman of Blinklab (ASX:BB1) presentation at this year's Stocks in the Vines Investor Access Day covering how Blinklab is revolutionizing the global med‑tech landscape by advancing innovative tools that support the early and accurate diagnosis of Autism in children. Their groundbreaking approach is helping clinicians and families worldwide access better insights and improved outcomes.
Alice Queen (ASX:AQX): Gold & Copper Exploration Update
Andrew Buxton
In this presentation, Executive Chairman Andrew Buxton outlines Alice Queen’s exploration strategy, project portfolio, and forward plans across its key gold and copper assets. He provides insight into recent progress, geological potential, and the company’s pathway toward value‑creating milestones. A concise and informative update for investors seeking exposure to early‑stage resource opportunities with strong discovery upside:
4DS Memory (ASX:4DS) Advancing Next‑Gen ReRAM Technology
David McAuliffe
In this presentation, Executive Director David McAuliffe provides a clear and compelling update on 4DS Memory’s progress in developing next‑generation non‑volatile memory technology. He outlines the company’s technical milestones, strategic partnerships, and the commercial potential of its Interface Switching ReRAM. Investors will gain insight into how 4DS is positioning itself within the global semiconductor landscape and the key catalysts shaping its path forward.
Presenter Perspectives: How Stocks in the Vines Drives Company Growth
